Target intelligence / Profile preview

Laminin-binding integrins

Molecular classification
Receptor, Integrin family, Cell adhesion molecule
01

Overview

Laminin-binding integrins, primarily comprising the heterodimers alpha-3/beta-1, alpha-6/beta-1, alpha-6/beta-4, and alpha-7/beta-1, are essential cell-surface receptors that mediate the attachment of epithelial and muscle cells to the laminin-rich basement membrane (Nishiuchi et al., 2006). These receptors are critical for maintaining tissue architecture and regulating diverse cellular processes, including survival, proliferation, and migration, through the activation of intracellular signaling cascades like the PI3K and MAPK pathways (Stewart & O'Connor, 2015). The alpha-6/beta-4 integrin is particularly notable for its role in forming hemidesmosomes, which provide mechanical stability to the skin by linking the extracellular matrix to the intermediate filament cytoskeleton (Wilhelmsen et al., 2006). In pathological contexts, these integrins are frequently hijacked by cancer cells to promote invasion, metastasis, and the survival of cancer stem cells, making them attractive targets for therapeutic intervention (Ramovs et al., 2017). While several monoclonal antibodies and peptides targeting these integrins are under investigation in preclinical and early clinical studies, no specific inhibitors have yet reached widespread clinical approval. Potential safety concerns for targeting this class include the risk of skin fragility and impaired wound healing, mirroring the phenotypes seen in genetic deficiencies like junctional epidermolysis bullosa (Has et al., 2020).

Other names
Alpha-6 integrin familyLaminin receptorsCD49f-containing integrinsVLA-6Integrin alpha-6 family
02

Mechanism of action

Antagonism of laminin binding to the extracellular domain of the integrin heterodimer, thereby preventing cell adhesion and disrupting pro-survival and pro-migratory signaling pathways such as PI3K/Akt and FAK/Src.

03

Biological functions

Cell adhesionSignal transductionCell migrationBasement membrane assemblyHemidesmosome formationCancer stem cell maintenance
04

Disease associations

CancerEpidermolysis bullosaMuscular dystrophyFibrosis
05

Safety considerations

Skin blisteringJunctional epidermolysis bullosa-like symptomsImpaired wound healingMuscle weakness
06

Interacting drugs

GoH3 (Experimental monoclonal antibody)

2 more in the full profile.

07

Biomarkers

CD49f (ITGA6) expressionIntegrin beta-4 (ITGB4) expressionLaminin-332 levels

Beyond the preview

Go deeper on Laminin-binding integrins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laminin-binding integrins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call